HIV-positive Status Disclosure and Associated Factors Among Children in Public Health Facilities in Dire Dawa, Eastern Ethiopia: A Cross-sectional Study
Overview
Affiliations
Introduction: HIV status disclosure in children is one of acontroversial issue in current health. Over 44,000 children in Ethiopia were living with HIV in the year 2019 with a variable level of disclosure, which ranges from 16.3% to 49%. Therefore, this study aimed to assess HIV-positive status disclosure and associated factors among HIV-infected children.
Methods: A cross-sectional study was conducted in ten public health facilities providing pediatric antiretroviral therapy services. Systematic random sampling was used to select 221 caregivers of children aged 6-15 years. Face-to-face interviews were employed to generate the data. Binary logistic regression was used to analyze the association between HIV-positive status disclosure to children and independent variables with statistical significance set at p-value <0.05.
Results: Out of the total, 134 (60.6%) of HIV-infected children knew about their HIV status. The mean age at disclosure was 10.71 years. Children aged older than 10 years [AOR = 22, 95% CI: 5.3-79.2], female children [AOR = 3; 95% CI = 1.2-8.7], children lost their family member by HIV [AOR = 3.5, 95% CI: 1.2-10], caregiver's perception of child did not get stigmatized [AOR = 4, 95% CI: 1.6-11], and children's responsible for anti-retroviral therapy [AOR = 16, 95% CI: 5-50] were significantly associated with HIV positive status disclosure compared to their counterpart respectively. Children who stayed on anti-retroviral for 10-15 years were [AOR = 7; 95% CI: 2-27] more likely to know their HIV positive status compared to those staying on anti-retroviral therapy for <6 years.
Conclusion: The proportion of disclosure of HIV-positive status among HIV-infected children was low. Factors associated were the age of the child, sex, existence of parent, stigma, ART duration, and responsibility of the child for his/her drugs. HIV care providers should consider these factors while supporting disclosure.
Chanie M, Abebe A, Muche A, Worku N HIV AIDS (Auckl). 2022; 14:461-472.
PMID: 36237554 PMC: 9553231. DOI: 10.2147/HIV.S356507.
Lemma T, Silesh M, Taye B, Desta K, Kitaw T, Tekalign T Front Public Health. 2022; 10:859469.
PMID: 35719618 PMC: 9201957. DOI: 10.3389/fpubh.2022.859469.
Armoon B, Fleury M, Higgs P, Bayat A, Bayani A, Mohammadi R Arch Public Health. 2022; 80(1):154.
PMID: 35681146 PMC: 9178876. DOI: 10.1186/s13690-022-00910-6.
Edun O, Shenderovich Y, Zhou S, Toska E, Okell L, Eaton J J Int AIDS Soc. 2022; 25(5):e25910.
PMID: 35543100 PMC: 9092159. DOI: 10.1002/jia2.25910.
Yami D, Tuji T, Gelete B, Beyene Workie K SAGE Open Med. 2022; 10:20503121211068725.
PMID: 35024145 PMC: 8744189. DOI: 10.1177/20503121211068725.